oxycodone ER
Marketedupdated 2mo agoby $COLL COLLEGIUM PHARMACEUTICAL, INC
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 30 investigational indications.
all catalysts(13)
approval · 13
Apr 26, 2016
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Sep 30, 2016
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Dec 16, 2016
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
May 26, 2017
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Nov 6, 2017
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Sep 18, 2018
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Sep 18, 2018
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Oct 26, 2018
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Oct 7, 2019
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Mar 4, 2021
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Dec 15, 2023
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Oct 31, 2024
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Dec 22, 2025
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that